MedPath

Takis

🇵🇦Panama
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers

Phase 1
Terminated
Conditions
COVID-19 Immunisation
Protection Against COVID-19 and Infections With SARS-CoV- 2
COVID-19
First Posted Date
2021-03-09
Last Posted Date
2023-03-29
Lead Sponsor
Takis
Target Recruit Count
68
Registration Number
NCT04788459
Locations
🇮🇹

San Gerardo Hospital, Monza, Italy

🇮🇹

Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy

🇮🇹

INMI Lazzaro Spallanzani, Rome, Italy

and more 1 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.